Rev-erbα heterozygosity produces a dose-dependent phenotypic advantage in mice. ‌ Ryan D Welch, Cyrielle Billon, Amina Kameric, Thomas P Burris, Colin A Flaveny

Ստացեք ամբողջական տեքստը

The LXR inverse agonist SR9238 suppresses fibrosis in a model of non-alcoholic steatohepatitis ‌ Kristine Griffett, Ryan D. Welch, Colin A. Flaveny, Grant R. Kolar, Brent A. Neuschwander-Tetri, Thomas P. Burris

Ստացեք ամբողջական տեքստը

Emerging Role of Nuclear Receptors for the Treatment of NAFLD and NASH ‌ Ryan D. Welch, Cyrielle Billon, McKenna Losby, Gonzalo Bedia-Diaz, Yuanying Fang, Amer Avdagic, Bahaa Elgendy, Thomas P. Burris, Kristine Griffett

Ստացեք ամբողջական տեքստը

Intestinal α1-2-Fucosylation Contributes to Obesity and Steatohepatitis in MiceSummary ‌ Rongrong Zhou, Cristina Llorente, Jinling Cao, Livia S. Zaramela, Suling Zeng, Bei Gao, Shang-Zhen Li, Ryan D. Welch, Feng-Qing Huang, Lian-Wen Qi, Chuyue Pan, Yan Huang, Pengchen Zhou, Iris Beussen, Ying Zhang, Gregory Bryam, Oliver Fiehn, Lirui Wang, E-Hu Liu, Ruth T. Yu, Michael Downes, Ronald M. Evans, Karrie Goglin, Derrick E. Fouts, David A. Brenner, Lars Bode, Xuegong Fan, Karsten Zengler, Bernd Schnabl

Ստացեք ամբողջական տեքստը